Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
作者
Matthew D. Galsky,Jürgen E. Gschwend,Matthew I. Milowsky,Michael Schenker,Begoña P. Valderrama,Yoshihiko Tomita,Aristotelis Bamias,Thierry Lebrét,Shahrokh F. Shariat,Se Hoon Park,Mads Agerbæk,Gautam Jha,Frank Stenner,Dingwei Ye,Fabio Giudici,Jessica Connors,Shilpa Gupta,Aparna Chhibber,J. Zhang,Dean F. Bajorin